|
Expansion of Recommendations for Hereditary Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
NCCN Guidelines® Insights - Myelodysplastic Syndromes, Version 2.2025 |
1.00 |
03/10/2025 - 12:00am to 03/10/2026 - 12:00am |
|
Updates in the Multidisciplinary Approach for Resectable Gastroesophageal Adenocarcinoma and Peritoneal-Limited Disease |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Beyond the Package Insert: Appropriate Interpretation of Testing Results for Targeted... |
1.00 |
03/10/2025 - 12:00am to 03/10/2026 - 12:00am |
|
Archived NCCN Tumor Boards: Acute Myeloid Leukemia: The Importance of Individualized Patient Care |
1.00 |
03/06/2025 - 12:00am to 03/06/2026 - 12:00am |
|
Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates |
1.00 |
02/21/2025 - 12:00am to 07/20/2025 - 12:00am |
|
NCCN Guidelines® Insights - Head and Neck Cancers, Version 2.2025 |
1.00 |
02/10/2025 - 12:00am to 02/10/2026 - 12:00am |
|
NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
02/04/2025 - 12:00am to 08/10/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer |
1.00 |
01/21/2025 - 12:00am to 01/21/2026 - 12:00am |
|
NCCN Guidelines® Insights - Lung Cancer Screening, Version 1.2025 |
1.00 |
01/10/2025 - 12:00am to 01/10/2026 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer |
1.00 |
11/01/2024 - 12:00am to 11/01/2025 - 12:00am |
|
NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
11/14/2024 - 12:00am to 07/13/2025 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Chemoimmunotherapy Updates in Advanced/Metastatic Non-Small Cell Lung Cancer |
1.00 |
11/12/2024 - 12:00am to 11/12/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Multidisciplinary Management of Head and Neck Cancers |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer |
1.00 |
10/28/2024 - 12:00am to 10/28/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward